Stock screener

AVR

Conviction 99HealthcareScan · Thu, Jun 25, 2026
AVR$9.87-5.10%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 1.28M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Anteris Technologies Global Corp.Medical Instruments & Supplieswww.anteristech.com
Price9.87
Change-5.10%
Gap-1.97%
Rel volume1.94×
Avg volume1.3M
Avg $ vol12.4M
SMA 209.45
SMA 507.84
SMA 2005.83
Price vs 50+25.93%
Price vs 200+69.36%
MA stackbullish
50/200 cross
Supertrendup · 8.30
RSI (14)61
MACD hist-0.03
MACD cross
Stoch %K / %D60 / 78
ADX (14)47
+DI / −DI25 / 8
RSI divergenceBearish
MACD divergenceBearish
ATR %+6.08%
ADR %6.36%
52w high10.40
52w low2.90
From 52w high-5.10%
Above 52w low+240.34%
New 52w highNo
SqueezeOff
Bollinger width18.17%
%B0.75
Donchian pos67.61%
Donchian high10.56
Donchian low8.43
AVWAP (52w high)10.12
vs AVWAP high-2.45%
AVWAP (52w low)6.55
vs AVWAP low+50.65%
OBV trendFlat
Chaikin MF (20)0.00
Today vs 20d1.94×
Avg vol (14d)1.28M
Avg vol (20d)1.3M
Avg $ vol (20d)12.4M
Market cap960.77M
RS 3m (vs SPY)+80.69%
RS 6m (vs SPY)+102.79%
RS line new highYes
Trend template8/8
Technical rank93.1
1 week+3.89%
1 month+8.70%
3 months+78.48%
6 months+85.53%
1 year+145.22%
YTD+100.61%
P/E-10.21
P/B3.45
P/S502.23
P/FCF-12.05
EPS-2.55
Div yield
ROE-33.81%
ROA-31.94%
Debt/Eq
Current20.93
EV/EBITDA-9.89
Gross margin
Net margin
Rev growth-29.23%
EPS growth-23.40%
Price target16.00
Target upside62.11%
Analyst ratingBuy
Institutional67.61%
Ent. value911.81M
Revenue494K
Net income-23.02M
Gross profit
Free cash flow-79.76M
IndustryMedical Instruments & Supplies
ExchangeNasdaq
Shares out97.34M
Employees174
ListedFri, Dec 13, 2024
Free float81.29M
Float %83.5%
Short interest5.42M
Days to cover3.6d
Short volume57.0%
Squeeze score57 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.28
Last surprise
Setup gradeA+
Conviction99 / 100
Pattern quality
Tech rank93.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance10.35
Support7.37
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AVR

All disclosures →
No recent disclosed trades by Congress in AVR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AVR · 4 buys · 5 sells

InsiderSideShares
Roberts David B
Director · Restricted Stock Units · 2026-06-07
Exercise17.58K
Roberts David B
Director · Common Stock · 2026-06-07
Exercise17.58K
Moss Gregory S.
Director · Common Stock · 2026-06-07
Exercise17.58K
Moss Gregory S.
Director · Restricted Stock Units · 2026-06-07
Exercise17.58K
McDonnell Matthew
Chief Financial Officer · Stock options · 2026-06-05
Exercise60K
McDonnell Matthew
Chief Financial Officer · Common Stock · 2026-06-05
Other
McDonnell Matthew
Chief Financial Officer · Common Stock · 2026-06-05
Exercise2K
McDonnell Matthew
Chief Financial Officer · Stock options · 2026-06-05
Exercise2K
McDonnell Matthew
Chief Financial Officer · Common Stock · 2026-06-05
Exercise60K
McDonnell Matthew
Chief Financial Officer · Common Stock · 2026-06-05
Tax39.59K

SEC filings

EDGAR filings in AVR

EDGAR →

No recent SEC filings on file for AVR.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.